 | A major contributor to this article appears to have a close connection with its subject. (May 2024) |
Vasant Kalathur Narasimhan M.D. | |
|---|---|
 Vasant Narasimhan | |
| Born | August 26, 1976 Pittsburgh, Pennsylvania, U.S. |
| Education | University of Chicago Harvard Medical School Harvard University, Kennedy School of Government |
| Occupation | CEO of Novartis |
| Spouse |
Srishti Gupta (m. 2003) |
| Children | 2 |
| Medical career | |
| Profession | Physician |
| Institutions | Novartis |
Vasant "Vas" Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis.[1][2][3][4] He succeeded Joseph Jimenez who left Novartis in 2018.[5] He briefly worked at McKinsey before joining Novartis in 2005, where he has held a range of leadership roles, including Global Head of Development for Novartis Vaccines and Global Head of Drug Development & Chief Medical Officer. [6]
- ^ Phadnis, Aneesh (2017-09-05). "Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis". Business Standard India. Retrieved 2018-08-15.
- ^ Bisserbe, Noemie (2018-02-18). "Novartis CEO Steers Drug Maker Back to R&D". Wall Street Journal. ISSN 0099-9660. Retrieved 2018-08-15.
- ^ Phadnis, Aneesh (5 September 2017). "Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis". Business Standard India. Retrieved 25 November 2019.
- ^ Dandekar, Vikas; Sukumar, C. R. (21 August 2018). "There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis". The Economic Times. Retrieved 25 November 2019.
- ^ "Novartis CEO Jimenez to Quit, Giving Reins to Harvard Doctor". Bloomberg.com. Bloomberg Technology. 4 September 2017. Retrieved 5 September 2017.
- ^ "Executive Profile – Vasant Narasimhan". Bloomberg. Retrieved 15 August 2018.